Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DRAFFT2 has recruited its first 2 patients in Southmead Hospital, Bristol. The trial is now also open in John Radcliffe Hospital Oxford, Peterborough City Hospital and Royal Stoke University Hospital.

The total number of participants to be recruited until May 2018 is 476.

For more information and contacts, please visit:

Similar stories

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report